Prolonged abstinence from tobacco smoking during the last 4 weeks of treatment (Day 43 to Day 70) as reported by direct inquiry of the patient by the Investigator, and confirmed by exhaled carbon monoxide (CO) levels, and plasma cotinine measurements. [clinicaltrials_resource:e8484667822d00f629d7184e5e20e32c]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Prolonged abstinence from tobacco smoking during the last 4 weeks of treatment (Day 43 to Day 70) as reported by direct inquiry of the patient by the Investigator, and confirmed by exhaled carbon monoxide (CO) levels, and plasma cotinine measurements. [clinicaltrials_resource:e8484667822d00f629d7184e5e20e32c]
Bio2RDF identifier
e8484667822d00f629d7184e5e20e32c
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:e8484667822d00f629d7184e5e20e32c
measure [clinicaltrials_vocabulary:measure]
Prolonged abstinence from toba ...... plasma cotinine measurements.
identifier
clinicaltrials_resource:e8484667822d00f629d7184e5e20e32c
title
Prolonged abstinence from toba ...... plasma cotinine measurements.
@en
type
label
Prolonged abstinence from toba ...... 84667822d00f629d7184e5e20e32c]
@en